CCMC Home - Outpatient Services
SPEECH THERAPY
   
 

speech

Speech Therapy
Director of Speech Therapy:
Brenda Bohnenblust, Speech Pathologist
bbohnenblust@ccmcks.org
785-632-2144 ext. 432

Speech Pathologists evaluate the patient, develop an individualized treatment for speech, language, cognitive communication, voice, swallowing, fluency, and other related speech difficulties.

SERVICES:

  • Video Fluoroscopy
  • Swallowing, including Vital Stim Therapy
  • Speech, Cognitive/Linguistic Therapy
  • Treatment of Fluency Disorders
  • Voice Therapy
  • LSVT LOUD

WHAT IS LSVT LOUD?

LSVT LOUD improves vocal loudness by stimulating the muscles of the voice box (larynx) and speech mechanism through a systematic hierarchy of exercises. Focused on a single goal “speak LOUD!” – the treatment improves respiratory, laryngeal and articulatory function to  maximize speech intelligibility. The treatment does not train people for shouting or yelling; rather, LSVT LOUD uses loudness training to bring the voice to an improved, healthy vocal loudness with no strain.

Treatment is administered in 16 sessions over a single month (four individual 60 minute sessions per week). This intensive mode of administration is consistent with theories of motor leaning and skill acquisition, as well as with principles of neural plasticity (the capacity of the nervous system to change in response to signals), and is critical to attaining optimal results. The treatment not only simulates the motor system but also incorporates sensory awareness training to help individuals with PD recognize that their voice is too soft, convincing them that the louder voice is within normal limits, and making them comfortable with their new louder voice.

Patients are trained to self-generate the adequate amount of loudness to make their speech understood. While LSVT LOUD has been successfully administered to individuals in all stages of PD, the treatment has been most effective among those who are in early or middle stages of the condition. LSVT LOUD has also been applied to individuals with sub-types of PD (Shy-Drager syndrome, multi-system atrophy and progressive supranuclear palsy), however the largest dataset is for individuals with Idiopathic Parkinson disease (IPD). Recently, LSVT LOUD has been applied to select individuals with stroke, multiple sclerosis, Down syndrome, and cerebral palsy with positive outcomes.

 


CCMC Home